Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents

Bioorganic & Medicinal Chemistry
2011.0

Abstract

A new series of 1,3-biarylsulfanyl derivatives (homodibenzyl core motif) have been designed and synthesized as new estrogen receptor ligands by chopping benzothiophene core of raloxifene to engender seco-raloxifene scaffold. All the synthesized compounds were screened for anti-proliferative, anti-osteoporotic, and anti-implantation activity. Compounds (35, 36) having basic amino anti-estrogenic side chain were exhibiting potential anti-proliferative activity in MCF-7, MDA-MB-231 and ishikawa cell lines. Some of the synthesized compounds having homodibenzyl motif (5, 8, 10) have shown moderate anti-osteoporotic activity.

Knowledge Graph

Similar Paper

Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents
Bioorganic & Medicinal Chemistry 2011.0
Synthesis and evaluation of raloxifene derivatives as a selective estrogen receptor down-regulator
Bioorganic & Medicinal Chemistry 2016.0
Recent advances in the synthesis of raloxifene: A selective estrogen receptor modulator
European Journal of Medicinal Chemistry 2012.0
Structure−Activity Relationships of Selective Estrogen Receptor Modulators:  Modifications to the 2-Arylbenzothiophene Core of Raloxifene
Journal of Medicinal Chemistry 1997.0
Discovery and Synthesis of [6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]- 2-(4-hydroxyphenyl)]benzo[b]thiophene:  A Novel, Highly Potent, Selective Estrogen Receptor Modulator
Journal of Medicinal Chemistry 1997.0
Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues:  Highly Potent Selective Estrogen Receptor Modulators
Journal of Medicinal Chemistry 1998.0
Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs
Bioorganic & Medicinal Chemistry Letters 2004.0
Solid-Phase synthesis and investigation of benzofurans as selective estrogen receptor modulators
Bioorganic & Medicinal Chemistry Letters 2002.0
Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs
Bioorganic & Medicinal Chemistry Letters 2004.0
Benzothiophene derivatives as selective estrogen receptor covalent antagonists: Design, synthesis and anti-ERα activities
Bioorganic & Medicinal Chemistry 2021.0